The United States’ Food and Drug Administration (FDA) has added a new warning the Johnson & Johnson Covid-19 vaccine after receiving reports of a rare but dangerous neurological condition.
The South African Health Products Regulatory Authority (SAHPRA) noted the recent warning but said that they will not be stopping the rollout of Johnson & Johnson jabs.
A small portion of the US population who received the Johnson & Johnson vaccine have developed Guillain-Barre syndrome.
The warning reads as follows:
Guillain Barré syndrome (a neurological disorder in which the body’s immune system damages nerve cells, causing muscle weakness and sometimes paralysis) has occurred in some people who have received the Janssen COVID-19 Vaccine. In most of these people, symptoms began within 42 days following receipt of the Janssen COVID-19 Vaccine. The chance of having this occur is very low. You should seek medical attention right away if you develop any of the following symptoms after receiving the Janssen COVID-19 Vaccine:
• Weakness or tingling sensations, especially in the legs or arms, that’s worsening and spreading to other parts of the body
• Difficulty walking
• Difficulty with facial movements, including speaking, chewing, or swallowing
• Double vision or inability to move eyes
• Difficulty with bladder control or bowel function
“Most people fully recover from Guillain-Barré,” the Washington Post claims.
Of the 12.5 million people who received the Johnson & Johnson vaccine, only a 100 people were diagnosed with the Guillian-Barre syndrome.
Sources: Business Insider, USSA news
Follow FiND iT on Facebook here.
ALSO READ: Johnson & Johnson claims vaccine can neutralize Delta variant
